AGN - Allergan + Cash Becomes More Compelling - February 12 Update

This is a mid-week update to the Analysts' Corner regular weekly AbbVie Allergan arbitrage updates.

This update is to provide details of current arbitrage opportunity in relation to AbbVie (ABBV) and Allergan (AGN) merger.

The following tables may usefully be read in conjunction with article, "Like AbbVie, Buy Allergan, It's A No-Brainer". But they also stand on their own.

Table 1 - Arbitrage Available At Time Of Purchase

Note a decrease in $ amount of arbitrage available Feb. 12, 2020. But the fewer days to estimated close date boost the percentage annualized return

Read more ...